CRL-1336

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCRL-1336

Drug Alias NameCRL-1336

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionP-glycoprotein 1 inhibitors

TargetsP-glycoprotein 1

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCytrx Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCytrx Corp

Active IndicationsN/A

Inactive IndicationsHematologic Neoplasms

ATC CodeN/A